Alternatives to the QALY measure for economic evaluations

Supportive Care in Cancer

Volumn 5, Issue 2, 1997, Pages 105-111

  Gafni, Amiram ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Economic evaluations; HYE; QALY; Quality of life; WTP

Indexed keywords

ARTICLE; CANCER PATIENT; HEALTH ECONOMICS; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION;

EID: 0030893146     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01262566     Document Type: Article

References (30)

1. Arrow KJ (1971) Uncertainty and the welfare economics of medical care. In: Arrow KH (ed) Essays in the theory of risk-bearing. Markham, Chicago, pp 177-219
2. Bell DE, Farquhar PH (1986) Perspectives on utility theory. Operations Res 34:179-183
3. Ben Zion U, Gafni A (1983) Evaluation of public investment in health care: Is the risk irrelevant? J Health Econ 2:161-165
4. Bleichrodt H (1995) QALYs and HYEs: under what conditions are they equivalent? J Health Econ 14:17-37
5. Broome J (1993) QALYs. J Publ Econ 50:149-167
6. Culyer AJ (1981) Health, economics and health economics. In: Vander-Gang J, Perlman M (eds) Health, economics and health economics. North-Holland, Amsterdam, pp 3-11
7. Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL, Rosen B (1996) Patient's preferences for therapy in advanced epithelial ovarian cancer: development, testing and application of a bedside decision instrument. Gynecol Oncol J 62:329-335
8. Evans RG (1984) Strained mercy: the economics of Canadian health care. Butterworths, Toronto
9. Fishburn PC (1988) Expected utility: an anniversary and a new era. J Risk Uncertainty 1:267-288
10. Gafni A (1991) Using willingness-topay as a measure of benefits: what is the relevant question to ask in the context of public decision making about health care programs. Med Care 29:1246-1252
11. Gafni A (1996) Proper preference based outcome measures in economic evaluations of pharmaceutical interventions. Med Care (in press)
12. Gafni A, Birch S (1991) Equity considerations in utility-based measures of health outcome in economic appraisals: an adjustment algorithm. J Health Econ 10:329-342
13. Gafni A, Birch S (1995) Preferences for outcomes in economic evaluations: an economic approach to addressing economic problems. Soc Sci Med 40:767-776
14. Gafni A, Birch S, Mehrez A (1993) Economics, health and health economics: HYEs versus QALYs. J Health Econ 12:325-339
15. Johannesson M (1995) The ranking properties of healthy years equivalents and quality adjusted life years under certainty and uncertainty. Int J Technol Assess Health Care 11:40-48
16. Kaplan RM, Feeny D, Revicki DA (1993) Methods for assessing relative importance in preference based outcome measure. Qual Life Res 2:467-475
17. Labelle RJ, Hurley JE (1992) Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities. J Health Econ 11:259-277
18. Levine MN, Gafni A, Markham B, MacFarlane B (1992) A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 117:53-58
19. Machina MJ (1987) Choice under uncertainty: problems solved and unsolved. Econ Perspect 1:121-154
20. Mehrez A, Gafni A (1989) Quality adjusted life years, utility theory, and healthy years equivalents. Med Decis Making 9:142-149
21. Mehrez A, Gafni A (1991) The healthy years equivalent: how to measure them using the standard gamble approach. Med Decis Making 11:140-146
22. Mishan EJ (1971) Elements of cost-benefit analysis. Allen and Unwin, London
23. Mooney G (1986) Economics, medicine and health care. Wheatsheaf, Brighton
24. O'Brien B, Gafni A (1995) When do 'dollars' make sense? Towards a conceptual framework for contingent valuation studies in health care. Med Decis Making 16:288-302
25. Phelps CE (1992) Health economics. Harper Collins, New York
26. Pliskin JS, Shephard DS, Weinstein MC (1980) Utility functions for life years and health status. Operations Res 28:206-224
27. Richardson J (1994) Cost-utility analysis: what should be measured? Soc Sci Med 39:7-21
28. Sebban C, Browman G, Gafni A, Norman G, Levine MN, Assouline D, Fiere D (1995) Design and validation of a bedside decision instrument to elicit a patient's preferences concerning allogenic bone marrow transplantation in chronic myeloid leukemia. Am J Hematol 48:221-227
29. Torrance GW, Feeny D (1989) Utilities and quality-adjusted life-years. Int J Technol Assess Health Care 3:559-575
30. Whelan TJ, Levine MN, Gafni A, Lukka H, Mohide EA, Patel M, Streiner DL (1995) Breast irradiation post lumpectomy: development and evaluation of a decision instrument. J Clin Oncol 13:847-853